MOTANA: study protocol to investigate motor cerebral activity during a propofol sedation.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
28 Aug 2019
Historique:
received: 11 12 2018
accepted: 18 07 2019
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 11 2 2020
Statut: epublish

Résumé

Accidental Accidental awareness during general anesthesia (AAGA) occurs in 1-2% of high-risk practice patients and is a cause of severe psychological trauma, termed post-traumatic stress disorder (PTSD). However, no monitoring techniques can accurately predict or detect AAGA. Since the first reflex for a patient during AAGA is to move, a passive brain-computer interface (BCI) based on the detection of an intention of movement would be conceivable to alert the anesthetist. However, the way in which propofol (i.e., an anesthetic commonly used for the general anesthesia induction) affects motor brain activity within the electroencephalographic (EEG) signal has been poorly investigated and is not clearly understood. For this reason, a detailed study of the motor activity behavior with a step-wise increasing dose of propofol is required and would provide a proof of concept for such an innovative BCI. The main goal of this study is to highlight the occurrence of movement attempt patterns, mainly changes in oscillations called event-related desynchronization (ERD) and event-related synchronization (ERS), in the EEG signal over the motor cortex, in healthy subjects, without and under propofol sedation, during four different motor tasks. MOTANA is an interventional, prospective, exploratory, physiological, monocentric, and randomized study conducted in healthy volunteers under light anesthesia, involving EEG measurements before and after target-controlled infusion of propofol at three different effect-site concentrations (0 μg.ml MOTANA is an exploratory study aimed at designing an innovative BCI based on EEG-motor brain activity that would detect an attempt to move by a patient under anesthesia. This would be of interest in the prevention of AAGA. Agence Nationale de Sécurité du Médicament (EUDRACT 2017-004198-1), NCT03362775. Registered on 29 August 2018. https://clinicaltrials.gov/ct2/show/NCT03362775?term=03362775&rank=1.

Sections du résumé

BACKGROUND BACKGROUND
Accidental Accidental awareness during general anesthesia (AAGA) occurs in 1-2% of high-risk practice patients and is a cause of severe psychological trauma, termed post-traumatic stress disorder (PTSD). However, no monitoring techniques can accurately predict or detect AAGA. Since the first reflex for a patient during AAGA is to move, a passive brain-computer interface (BCI) based on the detection of an intention of movement would be conceivable to alert the anesthetist. However, the way in which propofol (i.e., an anesthetic commonly used for the general anesthesia induction) affects motor brain activity within the electroencephalographic (EEG) signal has been poorly investigated and is not clearly understood. For this reason, a detailed study of the motor activity behavior with a step-wise increasing dose of propofol is required and would provide a proof of concept for such an innovative BCI. The main goal of this study is to highlight the occurrence of movement attempt patterns, mainly changes in oscillations called event-related desynchronization (ERD) and event-related synchronization (ERS), in the EEG signal over the motor cortex, in healthy subjects, without and under propofol sedation, during four different motor tasks.
METHODS METHODS
MOTANA is an interventional, prospective, exploratory, physiological, monocentric, and randomized study conducted in healthy volunteers under light anesthesia, involving EEG measurements before and after target-controlled infusion of propofol at three different effect-site concentrations (0 μg.ml
DISCUSSION CONCLUSIONS
MOTANA is an exploratory study aimed at designing an innovative BCI based on EEG-motor brain activity that would detect an attempt to move by a patient under anesthesia. This would be of interest in the prevention of AAGA.
TRIAL REGISTRATION BACKGROUND
Agence Nationale de Sécurité du Médicament (EUDRACT 2017-004198-1), NCT03362775. Registered on 29 August 2018. https://clinicaltrials.gov/ct2/show/NCT03362775?term=03362775&rank=1.

Identifiants

pubmed: 31455386
doi: 10.1186/s13063-019-3596-9
pii: 10.1186/s13063-019-3596-9
pmc: PMC6712668
doi:

Substances chimiques

Anesthetics, Intravenous 0
Propofol YI7VU623SF

Banques de données

ClinicalTrials.gov
['NCT03362775']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

534

Références

Clin Neurophysiol. 1999 Nov;110(11):1842-57
pubmed: 10576479
Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):198-204
pubmed: 11543846
J Postgrad Med. 2002 Jul-Sep;48(3):206-8
pubmed: 12432198
Clin Neurophysiol. 2003 Feb;114(2):376-90
pubmed: 12559247
Epilepsia. 2003;44 Suppl 12:2-8
pubmed: 14641556
Eur J Anaesthesiol. 2004 Jan;21(1):6-12
pubmed: 14768917
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
Anesth Analg. 2004 Sep;99(3):833-9, table of contents
pubmed: 15333419
Eur J Anaesthesiol. 2006 Nov;23(11):921-30
pubmed: 16723052
N Engl J Med. 2008 Mar 13;358(11):1097-108
pubmed: 18337600
Hum Brain Mapp. 2009 Jul;30(7):2157-72
pubmed: 18819106
Anesth Analg. 2009 Feb;108(2):527-35
pubmed: 19151283
Acta Anaesthesiol Scand. 2009 Aug;53(7):873-82
pubmed: 19496761
Curr Opin Anaesthesiol. 2009 Dec;22(6):782-7
pubmed: 19773649
Dtsch Arztebl Int. 2011 Jan;108(1-2):1-7
pubmed: 21285993
Exp Neurol. 2013 Jul;245:15-26
pubmed: 23022918
Clin Neurophysiol. 2013 Nov;124(11):2153-60
pubmed: 23757379
Biomed Tech (Berl). 2013 Sep 7;58 Suppl 1:
pubmed: 24042816
Electroencephalogr Clin Neurophysiol. 1989 Feb;72(2):184-7
pubmed: 2464490
Cochrane Database Syst Rev. 2014 Jun 17;(6):CD003843
pubmed: 24937564
Br J Anaesth. 2014 Oct;113(4):549-59
pubmed: 25204697
Br J Anaesth. 2015 Jul;115 Suppl 1:i20-i26
pubmed: 25735710
Br J Anaesth. 2015 Jul;115 Suppl 1:i32-i45
pubmed: 26174299
J Perioper Pract. 2015 Dec;25(12):257-61
pubmed: 26845787
J Neural Eng. 2016 Apr;13(2):026014
pubmed: 26859192
Bull World Health Organ. 2016 Mar 1;94(3):201-209F
pubmed: 26966331
Front Neurosci. 2017 Apr 13;11:205
pubmed: 28450827
Anaesthesia. 2018 Jan;73(1):112-122
pubmed: 29210043
Brain Imaging Behav. 2018 Oct;12(5):1513-1523
pubmed: 29260381
Front Neurosci. 2019 Jun 19;13:622
pubmed: 31275105
Neuroimage. 1997 Oct;6(3):201-8
pubmed: 9344824
Neuroimage. 1997 Apr;5(3):221-8
pubmed: 9345551

Auteurs

Sébastien Rimbert (S)

Université de Lorraine, Inria, LORIA, Neurosys team, 615 rue du Jardin Botanique, Vandoeuvre-lès-Nancy, France. sebastien.rimbert@inria.fr.

Denis Schmartz (D)

CHU Brugmann, Université Libre de Bruxelles, Place A.Van Gehuchten 4, Bruxelles, 1020, Belgium.

Laurent Bougrain (L)

Université de Lorraine, Inria, LORIA, Neurosys team, 615 rue du Jardin Botanique, Vandoeuvre-lès-Nancy, France.

Claude Meistelman (C)

Department of Anesthesiology and Critical Care Medicine, Universisty Hospital of Nancy, 9 Avenue de la Forêt de Haye, Vandoeuvre-lès-Nancy, 54500, France.

Cédric Baumann (C)

CHRU Nancy, plateforme d'aide à la recherche clinique, UMDS, Vandoeuvre-lès-Nancy, 54500, France.

Philippe Guerci (P)

Department of Anesthesiology and Critical Care Medicine, Universisty Hospital of Nancy, 9 Avenue de la Forêt de Haye, Vandoeuvre-lès-Nancy, 54500, France.
INSERM, U1116, Université de Lorraine, 615 rue du Jardin Botanique, Vandoeuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH